Elephas Biosciences
PrivateLast Round
Series B
Extension
Nov 6, 2025
Total Funding Raised
$164.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Elephas Biosciences operates in Healthcare & Life Sciences and is based in Madison, Wisconsin. Its latest recorded funding round was a Series B Extension round in November 2025.
Elephas Biosciences is a biotechnology company that develops a precision oncology platform utilizing artificial intelligence and advanced 3D imaging to test live patient tumor biopsies against potential therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elephas Biosciences Comparables
Compare Elephas Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Farcast Biodynamics | 87% | |
| Xsphera Biosciences | 87% | |
| Certis Oncology Solutions | 82% |
For institutional investors. Book with your work email.
Elephas Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Nov 6, 2025 | ||||
| Series C | Jan 23, 2024 | ||||
| Series B | Sep 6, 2022 | ||||
| Series A | Sep 15, 2021 | ||||
| Early Funding | May 21, 2021 | ||||
Seed | Apr 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Elephas Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| WARF Ventures | Series A, Series C, Series B |
| State of Wisconsin Investment Board | Series B Extension, Series C |
| Northpond Ventures | Series B Extension, Series C, Series B |
| Moore Strategic Ventures | Series C, Series B |
| Venture Investors Health Fund | Series B Extension, Series C |
| ARCH Venture Partners | Series B Extension, Series C, Series B |
| Venture Investors LLC | Series B Extension, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Grew 16% QoQ, from 141 to 163 employees.
- Apr 15, 2026
Partnering with Mithrl to accelerate research using their AI platform.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 6, 2026
Elephas participates in SITC 2026 in Arizona from Nov 4th–8th '26, presenting new functional precision medicine data, hosting a scientific symposium, and demonstrating its elive™ Edge instrument.
- partners_withSep 24, 2026
Elephas and Tes Pharma S.r.l. collaborate to evaluate TES-4207 in live human NSCLC tumor tissue as a monotherapy and in combination therapy to advance translational research for lung cancer therapy in Wisconsin on Sep 24th '26.
- partners_withAug 13, 2026
Elephas and Neuberg Diagnostics announce an exclusive commercial partnership in India on Aug 13th '26 to expand access to personalized oncology, with Neuberg Diagnostics bringing the elive platform into its laboratory infrastructure, aiming to launch a clinical test by the end of 2026 and serving as Elephas's research partner.
For institutional investors. Book with your work email.
Elephas Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elephas Biosciences's valuation, stock price, and market status.
Is Elephas Biosciences a public or private company?
Elephas Biosciences is a private company.
What is the current stock price of Elephas Biosciences?
Elephas Biosciences is a private company, so its shares have no public market price. Caplight tracks Elephas Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elephas Biosciences worth (valuation)?
Valuation information for Elephas Biosciences is not publicly available.
Can I buy Elephas Biosciences stock?
Elephas Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elephas Biosciences's last funding round?
Elephas Biosciences's most recent funding round was Series B Extension on November 6, 2025.
Who are the main investors in Elephas Biosciences?
Key investors in Elephas Biosciences include State of Wisconsin Investment Board, Venture Investors Health Fund, ARCH Venture Partners, Venture Investors LLC.
Will Elephas Biosciences IPO soon?
No public IPO plans have been announced for Elephas Biosciences.
How can I track Elephas Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Elephas Biosciences's shares on secondary markets.